1164 BSA01, a bispecific antibody-drug conjugate targeting EGFR and membrane-bound MUC-1-C, exhibits anti-tumor efficacy in vivo

• Hao Li,
• Yi Yang,
• Xiaopeng Li,
• Jia Zhang,
• Anqi Wang,
• W Frank An,
• Chaoshe Guo,
• Chengzhang Shang,
• Yifu Zhang,
• Yuji Liu,
• Gao An

Affiliations

Hao Li

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Yi Yang

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Xiaopeng Li

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Jia Zhang

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Anqi Wang

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

W Frank An

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Chaoshe Guo

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Chengzhang Shang

1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Yifu Zhang

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Yuji Liu

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Gao An

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China